Resveratrol and analogues: A review of antioxidant activity and applications to human health

Recent Patents on Food, Nutrition and Agriculture

Volumn 5, Issue 2, 2013, Pages 144-153

  Santos, Juliana A ^a   De Carvaho, Gustavo S G ^a   Oliveira, Virgínia ^a   Raposo, Nádia R B ^a   Da Silva, Adilson D ^a  

^a FEDERAL UNIVERSITY OF JUIZ DE FORA   (Brazil)

Author keywords

Antioxidant activity; Human health; Resveratrol; Resveratrol analogues; Stilbenes

Indexed keywords

EID: 84888387676     PISSN: 22127984     EISSN: 18761429     Source Type: Journal    
DOI: 10.2174/18761429113059990001     Document Type: Article

References (119)

1. Chong J, Poutaraud A, Hugueney P. Metabolism and roles of stilbenes in plants. Plant Sci 2009; 177: 143-55.
2. Robert M, Pizzirani D, Recanatini M, Simoni D, Grimaudo S, Di Cristina A, et al. Identification of a terphenyl derivative that blocks the cell cycle in the G0-G1 phase and induces differentiation in leukemia cells. J Med Chem 2006; 49: 3012-8.
3. Breinbauer R, Vetter IR, Waldmann H. From protein domains to drug candidates- Natural products as guiding principles in the design and synthesis of compound libraries. Angew Chem Int Ed 2002; 41: 2878-90. (Pubitemid 34966550)
4. Sinclair DA, Baur JA. Therapeutic potential of resveratrol: The in vivo evidence. Nat Rev Drug Discovery 2006; 5: 493-06. (Pubitemid 44136961)
5. Renaud S, de Lorgeril M. Wine, alcohol, platelets, and the French paradox for coronary heart disease. Lancet 1992; 339: 1523-6.
6. Baur JA, Pearson KJ, Price NL, Jamieson HA, Lerin C, Kalra A, et al. Resveratrol improves health and survival of mice on a highcalorie diet. Nature 2006; 444: 337-42. (Pubitemid 44764104)
7. Park EJ, Min HY, Ahn YH, Bae CM, Pyee JH, Lee, SK. Synthesis and inhibitory effects of pinosylvin derivatives on prostaglandin E2 production in lipopolysaccharide-induced mouse macrophage cells. Bioorg Med Chem Lett 2004; 14: 5895-8. (Pubitemid 39421540)
8. Heynekamp JJ, Webwe WM, Hunsker LA, Gonzales AM, Orlando RA. Substituted trans-stilbenes, including analogues of the natural product resveratrol, inhibit the human tumor necrosis factor alphainduced activation of transcription factor nuclear factor kappa B. J Med Chem 2006; 49: 7182-9. (Pubitemid 44886003)
9. Jang M, Cai L, Udeani GO, Slowing KV, Thomas CF, Beecher CW, et al. Cancer chemopreventive activity of resveratrol, a natural product derived from grapes. Science 1997; 275: 218-20. (Pubitemid 127696281)
10. Lion CJ, Matthews CS, Stevens MFG, Westwell AD. Identification of a terphenyl derivative that blocks the cell cycle in the G0-G1 phase and induces differentiation in leukemia cells. J Med Chem 2005; 48: 1292-5.
11. Roberti M, Pizzirani D, Simoni D, Rondanin R, Baruchello R, Bonora C, et al. Synthesis and biological evaluation of resveratrol and analogues as apoptosis-inducing agents. J Med Chem 2003; 46(16): 3546-54. (Pubitemid 36909831)
12. Velder J, Ritter S, Lex J, Schmalz HG. A simple access to biologically important trans-stilbenes via Ru-catalyzed cross metathesis. Synthesis 2006; 2: 273-8. (Pubitemid 43164412)
13. Cucciolla V, Borriello A, Oliva A, Galletti P, Zappia V, Della RF. Resveratrol: from basic science to the clinic. Cell Cycle 2007; 6: 2495-10. (Pubitemid 350058668)
14. Fabris S, Momo F, Ravagnan G, Stevanato R. Antioxidant properties of resveratrol and piceid on lipid peroxidation in micelles and monolamellar liposomes. Biophys Chem 2008; 135: 1-3.
15. Botella L, Nájara C. Synthesis of methylated resveratrol and analogues by Heck reactions in organic and aqueous solvents. Tetrahedron 2004; 60: 5563-70. (Pubitemid 38759336)
16. Gupta YK, Chaudhary G, Srivastava AK. Protective Effect of Resveratrol against Pentylenetetrazole-Induced Seizures and Its Modulation by an Adenosinergic System. Pharmacol 2002; 65: 170-4. (Pubitemid 34621753)
17. Chao J, Lia H, Chenga KW, Yub MS, Changb RCC, Wang MJ. Rotective effects of pinostilbene, a resveratrol methylated derivative, against 6-hydroxydopamine-induced neurotoxicity in SHSY5Y cells. Nut Biochem 2010; 21: 482-9.
18. Doeherty JJ, Fu MMH, Stifler BS, Limporos RJ, Pokabla CM, Delucia AL. Resveratrol inhibition of herpes simplex virus replication. Antivir Res 1999; 43: 135-45.
19. Chen ML, Li J, Xiao WR, Sun L, Tang H, Wang L, et al. Protective effect of resveratrol against oxidative damage of UVA irradiated HaCaT cells. Ban 2006; 31: 635-9. (Pubitemid 44645932)
20. Kim J, Lee HJ, Lee KW. Naturally occurring phytochemicals for the prevention of Alzheimer's disease. J Neurochem 2010; 112: 1415-30.
21. Anekonda TS. Resveratrol-a boon for treating Alzheimer's disease?. Brain Res Rev 2006; 5: 316-26. (Pubitemid 44291807)
22. Rivera L, Morón R, Zarzuelo A, Galisteo M. Long-term resveratrol administration reduces metabolic disturbances and lowers blood pressure in obese Zucker rats. Biochem Pharmacol 2009; 77: 1053- 63.
23. Dal-Pan A, Blanc S, Aujard F. Resveratrol suppresses body mass gain in a seasonal non-human primate model of obesity. BMC Physiology 2010, 10-1.
24. Baile CA, Yang JY, Rayalam S, Hartzell DL, Lai CY, Andersen C, et al. Effect of resveratrol on fat mobilization. Ann N Y Acad Sci 2011; 1215: 40-7.
25. Sun, B., Tang, L., Wang, Z., Hu, H., Yi, Y. Stilbene polymer, grape plant extract containing the same, and extraction method. CN 101182286 A 20080521 (2008).
26. Feng, T., Wang, Y., Zhuang, H., Yang, X. Extraction method of resveratrol and polydatin from grape seed. CN101704729A (2010).
27. Yang, Q., Zhang, C., Yu, S., Zhu, F., Liu, Y., Pan, L. Method for extraction of resveratrol from peanut root. CN101597214A (2009).
28. Yu, S., Zheng, X., Hong, S., Luo, D., Chen, L. Process for extraction and purification of resveratrol (res) from giant knotweed. CN 1760166A (2006).
29. Lu, C., Lu, Z. Process for extraction and purification of resveratrol from polygonum cuspidatum. CN101805755A (2010).
30. Wu, J., Shi, L. Method for extraction of resveratrol from Polygonum cuspidatum by microwave-aided extraction combined with enzymolysis. CN102070410A (2011).
31. Yang, Q., Zhang, C., Yu, S., Pan, L. Extraction of resveratrol from peanut root with cellulase-producing Aspergillus niger. CN 101353675A (2009).
32. Andersen, K.E., Borch, K., Krebs Lange, N.E., Steffen, E., Landvik, S., Schnorr, K.M. Plant extraction process using a lipolytic enzyme composition. WO2006111163A1 (2006).
33. Zhang, G., Han, H., Lei, J., Hao, J., Wang, D. Method for extracting resveratrol from Chinese medicine Polygonum. CN101993354 A (2011).
34. Cao, Y. Technology of supercritical carbon dioxide extraction of resveratrol from Polygonum cuspidatum. CN1513823A (2004).
35. Zu, Y., Yang, L., Zu, B., Zhang, L., Tian, H., Liu, Y., Xia, L., Jia, J., Niu, H. Method for recovering solid waste produced during resveratrol extraction. CN101033404A (2007).
36. Schubert, A., Haas, T., Schaffer, S., Tacke, T. Method for isolating stilbenoids from solvents. DE102009054984A1(2011).
37. Chen, S., Wu, X., Ma, M., He, Z., Zhang, Y., Zhao, J., Liu, J., Chen, S. Method for treating wastewater generated from extraction process of polygonum cuspidatum active components. CN 102060397A (2011).
38. Das S, Das DK. Anti-inflammatory responses of resveratrol. Inflamm & Allergy Drug Targets 2007; 6: 168-73. (Pubitemid 47455785)
39. Kang SS, Cuendet M, Endringer DC, Croy VL, Pezzuto JM, Lipton MA. Synthesis and biological evaluation of a library of resveratrol analogues as inhibitors of COX-1, COX-2 and NF-kappaB. Bioorg Med Chem 2009; 17: 1044-54.
40. Yu, C.W., Shin, Y.G., Chow, A., Li, Y.M., Kosmeder, J.W., Lee, Y.S., Hirschelman, W.H., Pezzuto, J.M., Mehta, R.G., Van Breemen, R.B. Human, rat, and mouse metabolism of resveratrol. Pharm Res 2002; 19: 1907-14. (Pubitemid 36016041)
41. Lin, Z., Zhong, J., Ni, T., Hu, Y., Gao, Y. cDNA and protein sequences for plant stilbene synthase and the use of enzyme for biosynthesis of resveratrol. CN1382693A (2002).
42. Chia, T.F., Ng, I. Transformation of stilbene synthase gene into plant and production of stilbenes in transgenic plants. WO 2002042465A1 (2002).
43. Lin, Z., Liu, S., Hu, Y. Transgenic lettuce expressing stilbene synthase (STS) gene derived from Parthenocissus henryana with high level of resveratrol production in the leaf. CN1748472A (2006).
44. Pyee, J-H., Hyung, N.I. Preparation of anticancer transgenic tomato expressing resveratrol biosynthesis gene from grape.WO 2002002053A2 (2002).
45. Pyee, J-H. Method for reducing toxic contents in tobacco by introducing stilbene synthase gene. WO2002000837A2 (2002).
46. Baek, S.H., Shin, U.C., Kang, H.J., Park, G.G., Kim, H.S., Kim, J.G. Rice containing resveratrol. KR2008012483A (2008).
47. Kim, S.Y., Seo, Y.B., Song, B.H. Resveratrol-reinforced grapes and production method thereof. KR2003021976A (2003).
48. Vivier, M.A., Pretorius, I.S., Lambrechts, M.G., Toit, M.D. Transgenic wine yeasts with a synthetic phenylpropanoid pathway for synthesis of resveratrol during fermentation. ZA2004008194A (2005).
49. Bru Martinez, R., Pedreno Garcia, M. Method for the production of resveratrol in cell cultures. WO2003062406A1 (2003).
50. Bru Martinez, R., Pedreno Garcia, M., Belchi Navarro, S., Almagro Romero, L. Combined use of methyl jasmonate and cyclodextrins for the production of resveratrol. WO2009106662A1 (2009).
51. Yun, C.H., Kim, D.H. Preparation of piceatannol using mutant bacterial cytochrome P450 BM-3. WO2010064764A1 (2010).
52. Yoon, Y.J., Park, S.R., Yoon, J.A., Baek, J.H., Park, J.W. Phenylpropanoid production using genetically engineered Streptomyces venezuelae. KR2010053741A (2010).
53. Rudinger, N., Schaffer, S., Hauberg, M. Fermentative production of resveratrol by Escherichia coli expressing plant 4-coumaroyl-CoA ligase and stibene synthase genes. DE102010023749A1 (2011).
54. Jerala, R., Avbelj, M., Bencina, M., Mori, J., Gaber, R., Koprivnjak, T., Anderluh, G. Improved synthesis of biosynthetic product by ordered assembly of biosynthetic enzymes guided by the nucleotide sequence motif template. WO2012053985A1 (2012).
55. Yan, R., Lin, Y. Improved method for synthesis of resveratrol with aluminum trichloride as catalyst. CN102050704A (2011).
56. Andrus, M., Meredith, E. Synthesis of resveratrol. WO 2001060774A1 (2001).
57. Deshpande, P.B., Senthilkumar, U.P., Andrew, G. Process for the preparation of tris-O-substituted-(E)-1-(3, 5-dihydroxyphenyl)-2-(4- hydroxyphenyl)ethene, an intermediate in the synthesis of transresveratrol. US6552213B1 (2003).
58. Chen, X., Mei, Y., Yu, A., Wang, K. Improved method for preparation of resveratrol. CN101033172A (2007).
59. Wang, W., Zou, J., Hua, Y., Liu, H. Method for synthesis of Resveratrol. CN1994991A (2007).
60. Yan, R., Ding, L., Feng, J., Fu, Y. Preparation of resveratrol from p-methoxybenzyl alcohol. CN1907931A (2007).
61. Schouteeten, A., Jus, S., Vallejos, J.C. Novel process for the synthesis of (E)-stilbene derivatives including resveratrol and piceatannol. WO2008012321A1 (2008).
62. Wiffen, J.W., Mccague, R. Process for preparation of polyhydroxylated stilbenes such as resveratrol. PT103940A (2009).
63. Mi, Q., Zeng, D. Simple and high-efficiency method for synthesis of trans-resveratrol. CN101585751A (2009).
64. Hu, Y., Xu, L., Huang, D., Xu, C. Novel method for synthesizing resveratrol with organic zinc halide reagent. CN101519342A (2009).
65. Gong, Z., Chen, Z., Wang, K., Liu, Q., Wu, Z. Method for synthesis of trans-resveratrol. CN101475451A (2009).
66. Gan, L. Improved method for synthesizing resveratrol. CN 101875600A (2010).
67. Gottumukkala, V.S., Masna, M., Hindupur, R.M., Thatipally, S. A key intermediate for the preparation of stilbenes. WO 2010010578 A2 (2010).
68. Gottumukkala, V.S., Masna, M., Hindupur, R.M., Thatipally, S. A key intermediate for the preparation of stilbenes. WO2010010578 A2 (2010).
69. Wang, F., Hu, W., Song, X., Xiang, J., Deng, S., Feng, F. Method for synthesis of trans-resveratrol via combined hydroxy-protection method. CN102079691A (2011).
70. Jiang, Y. Method for microwave-accelerated synthesis of resveratrol. CN102050702A (2011).
71. Subbaraj, G.V., Masna, M. An improved process for the preparation of resveratrol. IN2010CH00108A (2012).
72. Lançon A, Hanet N, Jannin B, Delmas D, Heydel JM, Lizard G, et al. Resveratrol in Human Hepatoma HepG2 Cells: Metabolism and Inducibility of Detoxifying Enzymes. Drug Metab Dispos 2007; 35: 699-03. (Pubitemid 46641555)
73. Fukuhara K, Nakanishi I, Matsuoka A, Matsumura T, Honda S, Hayashi M, et al. Effect of Methyl Substitution on the Antioxidative Property and Genotoxicity of Resveratrol. Chem Res Toxicol 2008; 21: 282-7.
74. Weng C-J, Yang Y-T, HO C-T, YEN GC. Mechanisms of Apoptotic Effects Induced by Resveratrol, Dibenzoylmethane, and Their Analogues on Human Lung Carcinoma Cells. J Agric Food Chem 2009; 57: 5235-43.
75. Fragopoulou E, Nomikos T, Karantonis HC, Apostolakis C, Pliakis E, Samiotaki M, et al. Biological Activity of Acetylated Phenolic Compounds. J Agric Food Chem 2007; 55: 80-9. (Pubitemid 46059125)
76. Sarpietro MG, Ottimo S, Giuffrida MC, Spatafora C, Tringali C, Castelli F. β-Cyclodextrins influence on E-3, 5, 4'- Trimethoxystilbene absorption across biological membrane model: A differential scanning calorimetry evidenceInt. J Pharm 2010; 388: 144-50.
77. Mathew S, Hedstrom M, Adlercreutz P. Enzymatic synthesis of piceid glycosides by cyclodextrin glucanotransferase. Process Biochem 2012; 47: 528-32.
78. Ryu G, Ju JH, Park YJ, Ryu SY, Choi BW, Lee BH. The radical scavenging effects of stilbene glucosides from Polygonum multiflorum. Arch Pharm Res 2002; 25: 636-9. (Pubitemid 43104186)
79. Tseng SH, Lin SM, Chen JC, Su YH, Huang HY, Chen CK, et al. Resveratrol Suppresses the Angiogenesis and Tumor Growth of Gliomas in Rats. Clin Cancer Res 2004; 10: 2190-02.
80. Garvin S, Ollinger K, Dabrosin C. Resveratrol induces apoptosis and inhibits angiogenesis in human breast cancer xenografts in vivo. Cancer Lett 2006; 231: 113-22. (Pubitemid 41779459)
81. Athar M, Back JH, Kopelovich L, Bickers DR, Kim AL. Multiple molecular targets of resveratrol: Anti-carcinogenic mechanisms. Arch. Physiol. Biophysical 2009; 486: 95-02.
82. Wang Z, Huang Y, Zou J, Cao K, Xu Y, Wu JM. Effects of red wine and wine polyphenol resveratrol on platelet aggregation in vivo and in vitro. Int J Mol Med 2002; 9: 77-9.
83. Das S, Alagappan VK, Bagchi D, Sharma HS, Maulik N, Das DK. Coordinated induction of iNOS-VEGF-KDR-eNOS after resveratrol consumption: A potential mechanism for resveratrol preconditioning of the heart. Vascul Pharmacol 2005; 42: 281-9. (Pubitemid 40726331)
84. + current in vascular endothelial cells. Cardiovasc Res 2000; 45: 1035-45.
85. Wu JM, Hsieh TC, Wang Z. Cardioprotection by resveratrol: A review of effects/targets in cultured cells and animal tissues. Am J Cardiovasc Dis 2011; 1: 38-47.
86. Lee JH, Song MY, Song EK, Kim EK, Moon WS, Han MK, et al. Overexpression of SIRT1 Protects Pancreatic β-Cells Against Cytokine Toxicity by Suppressing the Nuclear Factor-KB Signaling Pathway Diabetes 2009; 58: 344-51.
87. Denu JM. Fortifying the Link between SIRT1, Resveratrol, and Mitochondrial Function. Cell Metab 2012; 15: 566-7.
88. Shang J, Chen LL, Xiao FX, Sun H, Ding HC, Xiao H. Resveratrol improves non-alcoholic fatty liver disease by activating AMPactivated protein kinase. Acta Pharmacol Sin 2008; 29: 698-06. (Pubitemid 351799479)
89. Um JH, Park SJ, Kang H, Yang S, Foretz M, McBurney MW, et al. AMP-Activated Protein Kinase-Deficient Mice Are Resistant to the Metabolic Effects of Resveratrol. Diabetes March 2010; 59(3): 554-63.
90. Szkudelska K, Nogowski L, Szkudelski T. Resveratrol, a naturally occurring diphenolic compound, affects lipogenesis, lipolysis and the antilipolytic action of insulin in isolated rat adipocytes. J Steroid Biochem Mol Biol 2009; 113(1-2): 17-24.
91. Szkudelski T, Szkudelska K. Anti-diabetic effects of resveratrol. Ann N Y Acad Sci 2011; 1215: 34-9.
92. Chen WP, Chi TC, Chuang LM, Su MJ. Resveratrol enhances insulin secretion by blocking K(ATP) and K(V) channels of beta cells. Eur J Pharmacol 2007; 568: 269-77.
93. Bhatt JK, Thomas S, Nanjan MJ. Resveratrol supplementation improves glycemic control in type 2 diabetes mellitus. Nutrition Research 2012; 32(7): 537-41.
94. Hodis HN, Mack WJ, Azen SP, Lobo RA, Shoupe D, Mahrer PR, et al. Hormone Therapy and the Progression of Coronary-Artery Atherosclerosis in Postmenopausal Women. N Engl J Med 2003; 349(6): 535-45. (Pubitemid 36951365)
95. Gülçin I. Antioxidant properties of resveratrol: A structure-activity insight. Innovative Food Sci Emerg Technol 2010; 11(1): 210-8.
96. Ghanim H, Sia CL, Abuaysheh S, Korzeniewski K, Patnaik P, Marumganti A, et al. An Antiinflammatory and Reactive Oxygen Species Suppressive Effects of an Extract of Polygonum Cuspidatum Containing Resveratrol. JCEM 2010; 95: 9E1-E8.
97. Health food additive from Polygonum. Jpn. Kokai Tokkyo Koho (1985), JP60009455A (1985).
98. Uchiyama, T. Sparassis crispa extractions, resveratrol, and collagen peptide as antiaging agents and food supplements. JP2009234981 A (2009).
99. Xu, K. Production of composite functional food. CN101390609A (2009).
100. Souto, A.A. Composition containing vegetable oil and resveratrol, method for producing same and nutraceuticals containing said composition. WO2010091488A1 (2010).
101. Cui, X. Nutritional health product of pine pollen and natto. CN 101874628A (2010).
102. Pero, R.W., Garret, S. DNA-protecting nutritional supplement. US 20100215768A1 (2010).
103. Morte, D.D. Composition containing resveratrol, L-tryptophan, Laspartic acid and vitamin B3 for use in the pharmaceutical, nutritional and cosmetic fields .WO2012080952A1 (2012).
104. Hurst, W.J., Miller, K.B., Stuart, D.A. Cocoa ingredients having enhanced levels of stilbene compounds and methods of producing them. US20080268097A1 (2008).
105. Matsushita, S., Shirasaki, T., Okada, T., Murai, H. Skin-beautifying agents containing hydroxystilbenes. JP2008088123A (2008).
106. Baek, S.H., Shin, U.C., Kang, H.J., Park, G.G., Kim, H.S., Kim, J.G. Rice containing resveratrol. KR2008012483A (2008).
107. Ramarao, C., Alla, V.R.R. Yogurt related compositions containing polyphenols - resveratrol, fisetin and quercetin. WO2008120221 A1 (2008).
108. Mower, T.E., Brady, C.J. Dietary supplement drink for delivery of resveratrol and other polyphenols. WO2010135589A2 (2010).
109. Jin, G. Resveratrol complex and process for the preparation. CN 101565663A (2009).
110. Yoshikawa, M., Shibata, K., Asao, Y. Resak (Cotylelobium melanoxylon) extracts, their manufacture, pharmaceutical compositions containing the extracts or vaticanol G as hypoglycemics, etc., health food containing the compositions, and melanoxylin. JP 2009191049A (2009).
111. Tamura, A., Nakajima, Y. Food supplement comprising intestinal absorption stimulators. JP2009173570A (2009).
112. Kong, L., Wan, X., Ma, L., Wang, X. Application of resveratrol dimer in hypoglycemic drugs. CN101433534A (2009).
113. Matsukawa, T., Kishi, A., Nojima, M., Matsui, Y., Yamada, Y., Yamada, I. Manufacture and use of polymerized resveratrol compound or its pharmacologically acceptable salt, ester, or ether. JP 2011251914A (2011).
114. Xiao, K., Zheng, Y., He, X., Yang, L., Wang, Y., Lin, H., Xuan, L., Xu, Y., Zhang, L., Zhao, J. Pharmaceutical compositions containing extracts from Polygonum for treating AIDs and Hepatitis B. CN101214285A (2008).
115. Xiao, K., Jiang, Y., Cao, Y., Huang, J., Chen, W., Ding, X., Lin, H. Application of polydatin to prepare medical products for preventing, diagnosing, detecting, protecting, treating and studying dementia. CN101411716A (2009).
116. Robert, C., Wehner, S. Resveratrol extraction from Gnetum africanum and use in therapy or as cosmetics. WO2012012887A1 (2012).
117. Kato, Y., Hosoda, S. Novel stilbenoid compound and food materials, compositions, food, and cosmetics containing the same. JP 2010184886A (2010).
118. Kishi, A., Matsukawa, T., Doi, S., Nojima, M., Matsui, T., Yamada, Y., Yamada, I. Preparation of resveratrol derivative as anticancer agent. JP2012111735A (2012).
119. Kishi, A., Doi, S., Matsukawa, T., Matsui, T., Yamada, Y., Yamada, I. Process for production of hydroxystilbene derivatives having physiological activity. WO2012070656A1 (2012).